LUKA PETERNEL, MIHA KOTNIK, ANDREJ PREZ  ELJ, and UROŠ URLEB Cytotoxicity screening of new chemical entities in antibacterial drug discovery discerns between cytotoxic and antimicrobial activity, thus providing predictive evidence for selective toxicity. The objective of this study was to evaluate 3 cytotoxicity assays in identifying novel antibacterial hits with desired safety margins. The endpoints in assays comprised adenylate kinase (AK) release rate as an indicator of membrane rupture (Toxilight), intracellular adenosine triphosphate (CellTiter-Glo), and reduction of resazurin (CellTiter-Blue) both as indicators of cell metabolic activity. In the CellTiter-Glo and the CellTiter-Blue assays, 7 of 8 selected compounds showed cytotoxicity, whereas in the Toxilight assay, 3 of 8 compounds significantly reduced cell viability in the ChoK1 and the JurkatE6.1 cell line. The CellTiter-Glo assay proved to be the most sensitive among the evaluated assays, and excellent Z′ values were obtained in the 96-well plate (Z′ > 0.83). The CellTiter-Glo assay was clearly superior to the CellTiter-Blue and the Toxilight assay for the initial cytotoxicity screening. Moreover, the application of the CellTiter-Glo assay to determine mammalian cell toxicity versus the antibacterial effect ratio contributed to early identification of antibacterial hits with desired safety margins. The chemical structures of these novel antibacterial hits are disclosed herein. (Journal of Biomolecular Screening 2009:142-150) 
INTRODUCTION
T hE EssEnCE of AnTIMICroBIAl ThErAPy is selective toxicity, which means to kill or inhibit growth of the microbe without harming the patient. The bacterial cell wall represents a prime target because practically all bacteria, with the exception of mycoplasmas, possess a cell wall, whereas mammalian cells lack this feature. 1,2 on the other hand, several novel antimicrobials were also discovered and developed based on the distinction of essential physiological processes between bacteria and mammalian cells. 3, 4 In relation to toxicity, it is often assumed that because bacteria have evolved separately from eukaryotic cells, the products of essential genes that are not found in human cells are good targets for antibacterial screening. however, even when homology comparison does not show sequence homology, targeting the functional homolog of bacterial proteins in humans with significant overlap at the active sites has often demonstrated toxicity of new drug candidates. 5 lek Pharmaceuticals d.d., ljubljana, slovenia.
received Aug 21, 2008 , and in revised form oct 20, 2008 . Accepted for publication nov 4, 2008. Journal of Biomolecular screening 14 (2) ; 2009 DoI:10.1177/1087057108329452 historically, toxicity assessment of new chemical entities was performed in a progressive mode relatively late in drug discovery programs. 6 The main drawback of this approach is poor impact of toxicology on the drug design, which resulted in an increased drug attrition rate due to toxicology-related issues. 7 In antibacterial drug discovery programs, the first line of toxicity screening is represented by a cytotoxicity assay, which is a meaningful way to evaluate new antibacterials. however, cytotoxicity should not be interpreted as an ultimate result of selective toxicity because knowing the target in bacteria will further help to exclude any specific target-mediated toxicities. In our opinion, the cytotoxicity assay should be used in parallel with target inhibition or whole-bacteria efficacy assays. By using a parallel screening approach, more information for selecting quality hits for further development is obtained, and a chance of missing an important hit that may be less potent but safe is reduced. 8 Moreover, with such an approach, the selective toxicity is addressed early in a drug discovery process to raise alerts of relevant toxicological issues and provide direct feedback to a subsequent drug design. 6, 7 Various endpoints could be detected in early cytotoxicity assays, although a decision for a particular assay should consider also amenability to automation, required sensitivity, throughput, and acceptable costs. 9 Cytotoxicity can be assessed by quantifying the release of a constitutive cellular component, such as lactate dehydrogenase and adenylate kinase, and subsequent measurement of the released enzyme's activity in the culture supernatant. 10, 11 Alternatively, cell leakage also can be determined by measuring the intracellular enzyme's activity, which is lost when released into the extracellular media. 12 Another way of detecting cytotoxicity is by measuring cellular metabolic activity, which can be assessed by intracellular reduction of tetrazolium salts into colored formazan dyes or by intracellular reduction of resazurin into fluorescent resorufin. 13, 14 The high concentration of nucleic acids in cells can be coupled with fluorescent enhancement upon binding of particular stains. This makes nucleic acid stains another useful viability probe. 15 finally, cytotoxicity can be determined by bioluminescent detection of adenosine triphosphate (ATP), which plays a dominant role in energy exchange processes in biological systems and is therefore a reliable biomarker of cell viability. 16 Although the choice for a particular cytotoxicity assay is partly dictated by cost and availability, understanding the performance and limitations of available tools, kits, and reagents should be considered. The only way to find out is through a comparative experimental analysis. The aim of the present study was to compare 3 commercially available screening cytotoxicity assays and implement the most suitable one for the early identification of novel antibacterial hits with desired safety margins. Therefore, a toxicity versus efficacy ratio was introduced; the concentration of the compound that reduces the cell viability for 50% (TC 50 ) was used for the toxicity estimation, and the minimal inhibitory concentration (MIC) in the bacterial susceptibility assay was used for the efficacy estimation.
MATERIALS AND METHODS

Materials
All control compounds were purchased from sigma (st. louis, Mo). The compound stock solutions were prepared in 100% DMso. The final concentration of DMso in the culture media was 1% (cytotoxicity assay) and 2.5% (bacterial susceptibility assay). The CellTiter-Glo and the CellTiter-Blue kits were purchased from Promega (Mannheim, Germany). The Toxilight kit was purchased from lonza (Basel, switzerland). All microplates were purchased from Greiner Bio one (frickenhausen, Germany).
Cell culture
ChoK1 and JurkatE6.1 were obtained from ECAAC (salisbury, UK). The ChoK1 cell line was cultured in Dulbecco's modified Eagle's medium (DMEM) high-glucose media (90%; sigma) supplemented with fetal bovine serum (10%; Invitrogen, Carlsbad, CA) and adjusted to contain 2 mM glutamax (Invitrogen) and 0.1 mM nonessential amino acids (Invitrogen). In the present study, house passage number 3 was used. JurkatE6.1 cell line was cultured in rPMI media (90%; sigma) supplemented with fetal bovine serum (10%; Invitrogen) and adjusted to contain 2 mM glutamax (Invitrogen), 1 mM sodium pyruvate (Invitrogen), and 10 mM hEPEs (Invitrogen). In this study, house passage number 7 was used. The cells were cultured in exponential growth phase at 37 °C, 5% Co 2 , and 95% humidity.
Sensitivity of cytotoxicity assays, cell proliferation rate, and Z′ value
The ChoK1 cell line was seeded on a white 96-well plate, starting at 50,000 cells per 100 µl per well followed by 11 times 2-fold serial dilution and cultured for 48 h. The JurkatE6.1 cell line was seeded on a white 96-well plate, starting at 100,000 cells per 100 µl per well followed by 11 times 2-fold serial dilution and cultured for 24 h. At the end of the incubation period, CellTiter-Glo, CellTiter-Blue, and Toxilight kits were used as described below, with the exception that the AK release rate was determined after addition of 50 µl of the Toxilight complete lysis reagent per well (lonza).
To check the cell proliferation rate, we seeded the ChoK1 cells on a white 96-well plate at 12,500 cells per 100 µl per well, and the proliferation rate was determined by measuring the amount of intracellular ATP by using the CellTiter-Glo kit 24 h and 48 h after seeding, as described below. The JurkatE6.1 cell line was seeded at 25,000 cells per 100 µl per well and cultured for 24 h. The proliferation rate was determined by using the CellTiter-Glo kit immediately and 24 h after seeding, as described below.
Z′ value was determined for all cytotoxicity assays according to Zhang et al. 17 Tamoxifen (100 µM) was used as a positive control. Each plate comprised half of the plate wells with the positive control and the other half of the plate wells with the negative (vehicle only) control.
Cytotoxicity assays
Compounds were serially 2-fold diluted 8 times with 100% DMso and dispensed to a white 96-well microplate just prior to the seeding of JurkatE6.1 cells or 24 h after the seeding of ChoK1 cells. JurkatE6.1 cells were seeded at 25,000 cells per 100 µl per well, whereas ChoK1 cells were seeded at 12,500 cells per 50 µl per well. With the 384-well plate format, JurkatE6.1 cells were seeded at 10,000 cells per 40 µl per well, whereas ChoK1 cells were seeded at 4000 cells per 40 µl per well. After the compound addition, the plates were incubated for 24 h, followed by the cytotoxicity assays as described below. Each microplate included positive and negative control wells.
The adenylate kinase (AK) release rate was determined in the supernatant samples with the Toxilight kit according to the manufacturer's procedures. Briefly, the 96-well plate was equilibrated at room temperature for 30 min, followed by 20 µl supernatant transfer into a new 96-well plate and addition of 100 µl of the Toxilight reagent per well. The plate was then equilibrated at room temperature for 5 min, and luminescence was recorded on the Infinite 200 (Tecan, Mannedorf, switzerland). The original plate was used for the subsequent CellTiter-Glo or CellTiter-Blue assay.
The amount of intracellular reduction of resazurin into resorufin was determined with the CellTiter-Blue kit according to the manufacturer's procedures. Briefly, 20 µl of the CellTiter-Blue reagent was added per well of the 96-well plate, followed by orbital shaking at 100 rpm for 10 s. The plate was then returned into a Co 2 incubator for an additional 2 h, followed by fluorescence reading at an excitation/emission wavelength of 560/590 nm on the Infinite 200 (Tecan). When the CellTiter-Blue assay was applied to the 384-well plate, 5 µl of the CellTiter-Blue kit was added to each well, followed by the same procedures as described for 96-well plate format.
The intracellular amount of ATP was determined by the CellTiter-Glo kit according to the manufacturer's procedures. Briefly, the 96-well plate was equilibrated at room temperature for 30 min, followed by the addition of 100 µl of the CellTiter-Glo reagent per well. The plate was then mixed for 2 min on an orbital shaker at 400 rpm and incubated at room temperature for a further 10 min, followed by luminescence recording on the Infinite 200 (Tecan). When the 384-well plate format was used, 40 µl of the CellTiter-Glo reagent was added per well, followed by the same procedures as described for the 96-well plate format.
Bacterial susceptibility assay
Bacterial susceptibility, expressed as MIC, was determined by the microbroth dilution technique using the cationadjusted Mueller-hinton medium (CAMhB; sigma) as recommended by the Clinical and laboratory standards Institute (ClsI). 18 The inocula of Escherichia coli (ATCC 27325) and Staphylococcus aureus (ATCC 25923) were prepared by the direct colony suspension method. The single colonies from the bacteria grown on blood agar plates at 35 °C for 24 h were suspended in 2 ml of saline and further diluted with CAMhB to obtain a final inoculum of 5 × 10 5 CfU/ml. After the plates were incubated at 35 °C for 18 to 24 h, MICs were determined in duplicate by an unaided eye. Each microplate included positive and negative growth control wells. In addition, the assay was routinely monitored by testing standard antibiotics and ensuring that MIC values were within the recommended ranges for the respective control strains. MIC was defined as the minimum inhibitory concentration (µg/ ml) of antibiotic at which no visible bacterial growth occurred. Compound final concentrations ranged from 1 µg/ ml to 128 µg/ml.
Statistical analysis
relative viability was calculated by the following equation:
Concentration of the compound, which reduces cell viability for 50% (TC 50 ), was determined by a 4-parameter logistic equation:
where the top and bottom were constrained to 100 and 0, respectively. y is relative cell viability, n is the hill slope, and X represents the logarithm of the compound concentration. The signal-to-noise (s/n) ratio was calculated as follows:
(3) standard deviation background
The limit of detection was defined as the number of cells required to give a signal equal to the background plus 3 times the standard deviation of the background, which equals an s/n of 3. A correlation analysis was used to delineate how consistently TC 50 values obtained from different assays vary together, and the magnitude of correlation was expressed by the correlation coefficient (r). The value of p < 0.05 was considered significant for all the parameters measured. All data are given as mean ± standard error of mean (sEM). statistical analysis was supported by GraphPad Prism Version 4.02 for Windows (GraphPad software, san Diego, CA).
RESULTS
Sensitivity, proliferation rate, and Z′ values
The superior s/n ratio was obtained in the CellTiter-Glo assay when compared with the CellTiter-Blue and the Toxilight assays in both cell lines (Fig. 1) . With the CellTiter-Glo assay, we were able to detect cells seeded at 50 (ChoK1) and 98 (JurkatE6.1) cells per well. A similar result was also obtained by the Toxilight assay but only in the ChoK1 cell line. By using the CellTiter-Blue assay, this limit was increased up to 3125 cells per well in both cell lines. The linear regression analysis revealed good correlation between the s/n ratio and the number of cells per well for all evaluated assays, with a coefficient of determination (r 2 ) greater than 0.81. mean (vehicle) − mean (background) regarding Z′ values, the CellTiter-Glo assay showed excellent values in the JurkatE6.1 (0.85 ± 0.05; n = 3 full 96-well plates) and the ChoK1 (0.87 ± 0.01; n = 5 full 96-well plates) cell lines. similar results were also obtained by the CellTiter-Blue assay, where the mean Z′ value was 0.77 ± 0.02 in the JurkatE6.1 cell line (n = 3 full 96-well plates) and 0.83 ± 0.02 in the ChoK1 cell line (n = 3 full 96-well plates). low background luminescence of the CellTiter-Glo assay resulted in more than a 150-fold separation of signals between viable and dead cells, whereas the separation in the CellTiter-Blue assay was only 5-fold. Z′ values of the Toxilight assay were lower in the JurkatE6.1 (0.51 ± 0.10; n = 3 full 96-well plates) and ChoK1 (0.66 ± 0.04; n = 3 full 96-well plates) cell lines. In the Toxilight assay, approximately 6-fold separation of signals between viable and dead cells was observed.
The cell proliferation rate within the cytotoxicity incubation period was inspected to check the suitability of the seeding density to induce the exponential growth phase. The selected seeding density was 12,500 cells per 100 µl per well for the ChoK1 cell line and 25,000 cells per 100 µl per well for the JurkatE6.1 cell line. At higher seeding densities, an increase of the AK release rate was observed, thus indicating cell deterioration. The population of the ChoK1 and the JurkatE6.1 cells increased 1.5 times and 2 times within the 24-h incubation period, respectively. Therefore, those cells are, in addition to FIG. 1. sensitivity of cytotoxicity assays. ChoK1 and JurkatE6.1 cell lines were seeded on a white 96-well plate starting at 50,000 cells per 100 µl per well and 100,000 cells per 100 µl per well, respectively, followed by 11 times 2-fold serial dilution. The dotted line represents the limit of detection, defined as a signal-to-noise ratio (s/n) of 3. The s/n was calculated from 4 observations. screening for direct cytotoxicity, suitable also for divisionarrested-mediated cytotoxicity screening.
Cytotoxicity of control compounds
Tamoxifen, 19 clozapine, 20 troglitazone, 21 chlorpromazine, 22 diclofenac, 23 methyl methanesulfonate, 24 rifampicin, 25 and acetaminophen 26 were chosen for the assessment of prediction power of cytotoxicity assays described herein. The summary of the cytotoxic effects of tested compounds obtained by the CellTiter-Glo, CellTiter-Blue, and Toxilight assays is shown as the TC 50 values in Table 1 . The CellTiter-Glo and the CellTiter-Blue assays detected 7 of 8 compounds as cytotoxic. The ranking order of cytotoxicity was chlorpromazine > tamoxifen > clozapine > troglitazone = rifampicin > diclofenac > methyl methanesulfonate > acetaminophen in the JurkatE6.1 cell line and tamoxifen > chlorpromazine > clozapine = troglitazone > rifampicin > methyl methanesulfonate > diclofenac > acetaminophen in the ChoK1 cell line. Acetaminophen was not cytotoxic in either the JurkatE6.1 or ChoK1 cell line, probably due to an inability of used cell lines to metabolize acetaminophen into a respective cytotoxic metabolite. 26 surprisingly, by using the Toxilight assay, only tamoxifen was detected as cytotoxic in both cell lines, whereas chlorpromazine, clozapine, and methyl methanesulfonate were detected as cytotoxic in 1 of 2 cell lines only ( Table 1) .
A significant correlation was observed between the TC 50 values obtained from the CellTiter-Glo and the CellTiter-Blue assays in the JurkatE6.1 (r = 0.99) and ChoK1 (r = 0.85) cell lines. on the other hand, correlation between the Toxilight assay and the CellTiter-Blue or the CellTiter-Glo assay was rather poor (r < 0.62) and was not considered significant in either the JurkatE6.1 or ChoK1 cell line.
Application of the TC 50 /MIC ratio for identification of novel antibacterial hits
The TC 50 value obtained by the CellTiter-Glo assay was chosen as a parameter for the estimation of cytotoxicity, and the MIC value obtained from bacterial susceptibility assay was used for the estimation of antibacterial efficacy of investigated compounds. According to the TC 50 /MIC ratio, investigated compounds fell into 1 of 3 classes (Fig. 2) . The first class is represented by compounds that possess an antibacterial activity at concentrations that are also harmful to the mammalian cells (TC 50 /MIC < 2). The second class is composed of compounds with antibacterial activity at concentrations below the TC 50 , but the safety margins in this class of compounds are still not adequate (2 < TC 50 /MIC < 10). And the third class is represented by the most promising compounds with desired antibacterial activity and with acceptable safety margins above the arbitrary threshold (TC 50 /MIC > 10). The chemical structures of compounds with the acceptable safety margins are shown in Table 2 . such compound prioritization is justified by the classification of approved antibacterials (ciprofloxacin, oxacillin, rifampicin, vancomycin, fosfomycin, and D-cycloserine) into the area of interest and by the classification of known cytotoxins with no reported antibacterial activity into the alert area (chlorpromazine, tamoxifen, and clozapine).
DISCUSSION
The goal of the cytotoxicity screening in the discovery of new antibacterials is not necessarily to identify the best compound but rather to identify active hits that have attributes that are good enough to become successful drugs after chemotype optimization. In other words, the main goal of the initial cytotoxicity screen is compound classification and not investigation of the mechanism of cytotoxicity. In general, cytotoxicity screens are applied only for compounds that pass the desired antibacterial activity criteria in the first-line antibacterial efficacy screening campaign. By using such an approach, seemingly little concern is given to missing important leads that may be less potent but safe. such missed opportunities can be considered false negatives. 8 Therefore, it is paramount to perform antibacterial efficacy and cytotoxicity assays in parallel, resulting in instant determination of the TC 50 /MIC ratio and thereby of safety margins.
Determination of the MIC values is a well-established method 18 and was not evaluated in detail in the present report. on the other hand, there is no generally accepted method for the assessment of cytotoxicity, especially with regard to the used cell line, endpoints, and assessment criteria. some compounds can be cytotoxic against all cell types at similar concentrations, whereas others exhibit species-or cell type-specific cytotoxicity. Closely related cell types and analogous cell types in humans and rodents frequently have shown different patterns of cytotoxicity. 27 however, published data are contradictory, as schoonen et al. 28 reported that cell lines are usually responsive to the same set of compounds, but the magnitude of cytotoxicity might differ among different cell lines. Moreover, Bugelski et al. 8 reported that the linear regression analysis for the TC 50 values, whether conducted on a tissue-bytissue or individual cell line basis, revealed a strong, statistically significant linear relationship between tissues and between cell lines. We conclude that the most meaningful way of performing the cytotoxicity screen is to use 2 cell lines of different sensitivity to cytotoxins-for example, a more sensitive JurkatE6.1 and a less sensitive ChoK1 cell line. By using such an approach, missed opportunities with false negatives and positives are less likely to occur.
The cytotoxicity endpoints reflect the physiological condition of the cell and should be easily measured, sensitive, robust, and compatible with automated assay execution. 9 As judged by good prediction power to detect cytotoxicity and good Z′ values, the CellTiter-Glo and the CellTiter-Blue assays could both be used for screening purposes. however, better sensitivity and the homogeneous mix-and-measure assay execution favors the usage of the CellTiter-Glo assay. With regard to the Toxilight assay, its main drawback was low prediction power to detect cytotoxicity under experimental conditions used, which could be attributed to inability of the Toxilight assay to measure current conditions in the cell. 29 The interaction of the cell with the investigated compound could result in a decreased metabolic activity, and although such a compound is cytotoxic, the Toxilight assay would not be able to detect it due to retained membrane integrity. The usage of the Toxilight assay instead of the CellTiter-Glo assay, with regard to cytotoxicity, would result in false negatives. Each cytotoxic endpoint reflects a particular condition of the cell, and it has been proposed that measuring several endpoints simultaneously in a single well could provide more informational content about a compound. 30 however, the direction and magnitude of correlation between the TC 50 values obtained from the CellTiter-Glo and the CellTiter-Blue assays were close to 1, implying that these 2 assays produced highly comparable results. Therefore, using only the CellTiter-Glo is deemed sufficient for the assessment of cell viability in first-line cytotoxicity screening. 8 The concentration-dependent cytotoxicity TC 50 , defined as the concentration of the compound that reduces the cell viability for 50%, was calculated. The TC 50 value was plotted against the MIC value to determine the safety margins of a particular compound. By such an approach, several new thiosemicarbazone (compounds 1 and 2), n-sulfonyl glutamic acid (compounds 3-6), thio-and oxadiazole (compounds 7-11), and rhodanine (compounds 12 and 13) class of compounds with the TC 50 /MIC > 10 were easily identified ( Table 2 ). In addition, some structurally unrelated compounds with acceptable safety margins were also identified (compounds [14] [15] [16] [17] [18] . Their antibacterial value and potential for further development will be assessed on broader MIC screening, in mode-of-action studies, and by resistance frequency determination followed by chemical refinement and subsequent stages of the appraisal of any new antibacterial. It should be noted that some compounds in the "gray area" (2 < TC 50 /MIC < 10) could still represent promising hits, but it should be delineated whether the antibacterial efficacy and cytotoxicity are of the same mechanistic origin. Knowing the target in bacteria would help exclude any specific target-mediated toxicities. on the other hand, compounds with TC 50 /MIC < 2 are deemed of less importance for further development without extensive optimization effort.
In conclusion, the CellTiter-Glo assay was considered a reliable assay for the initial cytotoxicity screening using the ChoK1 and the JurkatE6.1 cell lines. In addition, the concept of the TC 50 /MIC ratio allows prompt selection of antibacterial hits picked up for further characterization and optimization.
